|
2025
|
Invention
|
Method for enhancing productivity of clones expressing pembrolizumab. The present invention relat... |
|
|
Invention
|
Stable liquid formulation of pembrolizumab. The present invention provides stable liquid pharmace... |
|
|
Invention
|
Novel high concentration phesgo formulation. The present invention provides high concentration li... |
|
|
Invention
|
Method for modulation of daratumumab glycosylation profile. 22 with pH of cell culture. |
|
2024
|
Invention
|
Method for modulating afucosylation level of pertuzumab. The present invention provides a method ... |
|
|
Invention
|
Method for reducing oxidation levels in vedolizumab during cell culture process. The present inve... |
|
|
Invention
|
Method for improving galactosylation profile and reducing oxidized species in production of pembr... |
|
|
Invention
|
Pharmaceutical composition of pirtobrutinib. The present invention relates to the pharmaceutical ... |
|
|
Invention
|
Stable liquid citrate free formulation of an anti-α4β7 antibody. The invention provides stable li... |
|
|
Invention
|
Daptomycin formulation. The present invention is related to a stable lyophilized pharmaceutical c... |
|
|
Invention
|
Pharmaceutical composition of daptomycin.. The present invention is related to a stable lyophiliz... |
|
|
Invention
|
An orodispersible pharmaceutical solid dosage form of safinamide. The present invention is relate... |
|
|
Invention
|
Edoxaban formulation.. The present invention is related to a pharmaceutical composition of edoxab... |
|
|
Invention
|
Method for conjugation and purification of antibody drug conjugate. The present invention relates... |
|
|
Invention
|
Codon optimized polynucleotide encoding human factor ix. The present invention relates to polynuc... |
|
2023
|
Invention
|
Pharmaceutical composition comprising rupatadine and montelukast. The present invention relates t... |
|
|
Invention
|
Upadacitinib formulation. The present invention is related to pharmaceutical composition of upada... |
|
|
Invention
|
Stable liquid formulation of an anti-α4ß7 antibody. The invention provides stable liquid formulat... |
|
|
Invention
|
An orodispersible tablet of rivaroxaban. The present invention relates to an orodispersible table... |
|
|
Invention
|
Multi-component buffer system for purification of antibodies.
The present invention relates to m... |
|
|
Invention
|
Multi-component buffer system for purification of antibodies. The present invention relates to mu... |
|
2022
|
Invention
|
A stable extended release pharmaceutical composition of clozapine. The present invention provides... |
|
|
Invention
|
An extended release pharmaceutical composition of clozapine. 0-24hmaxminmin in the patient's plas... |
|
|
Invention
|
An orodispersible pharmaceutical dosage form of edoxaban. The present invention relates to an oro... |
|
|
Invention
|
Extended release pharmaceutical composition of clozapine. An extended release pharmaceutical comp... |
|
|
Invention
|
Stable lyophilized formulation of an anti-α4ß7 antibody. The invention provides stable lyophilize... |
|
|
Invention
|
A stable ready to dilute injectable pharmaceutical formulation of mitomycin. The present inventio... |
|
|
Invention
|
Stable extended release pharmaceutical composition of clozapine. Disclosed are stable extended re... |
|
|
Invention
|
Extended release pharmaceutical composition of clozapine. min in patient plasma that are within 8... |
|
|
Invention
|
Essentially sodium-free effervescent solid pharmaceutical compositions.
Essentially sodium-free ... |
|
|
Invention
|
Oral pharmaceutical composition of arsenic trioxide.
The present invention provides oral pharmac... |
|
|
Invention
|
Oral pharmaceutical composition of arsenic trioxide. The present invention provides oral pharmace... |
|
|
Invention
|
An orodispersible pharmaceutical solid dosage form of rasagiline.
The present invention relates ... |
|
|
Invention
|
An orodispersible pharmaceutical solid dosage form of rasagiline. The present invention relates t... |
|
|
Invention
|
An improved peg-gcsf purification process having dual ufdf. The invention relates to an improved ... |
|
2021
|
Invention
|
Gene therapy based administration of lentivirus vector for treating hemoglobinopathies.
The inve... |
|
|
Invention
|
Gene therapy based administration of lentivirus vector for treating hemoglobinopathies. The inven... |
|
|
P/S
|
Pharmaceutical preparations for human use; pharmaceutical preparations for the treatment of verti... |
|
|
Invention
|
Process for preparation of recombinant adeno-associated virus particle. The present invention rel... |
|
|
Invention
|
Adeno-associated virus vector delivery of micro-dystrophin to treat muscular dystrophy. rAAV base... |
|
|
Invention
|
An anti-vegf scfab adeno-associated virus (aav) vector and uses thereof. Adeno-associated virus b... |
|
|
Invention
|
An anti-vegf scfv adeno-associated virus (aav) vector and uses thereof. The present invention dis... |
|
|
P/S
|
Pharmaceutical preparations and substances; pharmaceutical preparations and substances for the tr... |
|
2020
|
P/S
|
Clinical trials; clinical research; testing of pharmaceuticals; providing information about the r... |
|
|
Invention
|
Pharmaceutical composition comprising hmg-coa reductase inhibitors and fenofibrate.
A multilayer... |
|
|
Invention
|
Pharmaceutical composition of temozolomide.
A stable pharmaceutical composition of temozolomide ... |
|
|
Invention
|
Pharmaceutical composition of imatinib.
A pharmaceutical composition having imatinib or its phar... |
|
|
Invention
|
Stable oral composition of cyclophosphamide. A stable oral composition for cyclophosphamide or it... |
|
|
Invention
|
Naltrexone formulation.
A lactose free, stable pharmaceutical composition having naltrexone or i... |
|
|
Invention
|
Stable formulation of cetrorelix.
The present invention relates to a stable formulation of Cetro... |
|
|
Invention
|
Stable, ready to use aqueous pharmaceutical composition of pemetrexed. The present invention prov... |
|
|
Invention
|
Process for preparation of tofacitinib and pharmaceutically acceptable salt thereof. The present ... |
|
|
Invention
|
A process for preparation of a stable pharmaceutical composition of bortezomib.
The present inve... |
|
2019
|
P/S
|
Effervescent pharmaceutical preparations. Scientific and technical research and development in th... |
|
|
P/S
|
Pharmaceutical compositions comprising of solifenacin. |
|
2015
|
P/S
|
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic ... |
|
|
P/S
|
Scientific research in relation to prescription-only human or veterinary medicines for parenteral... |
|
2009
|
P/S
|
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; Plasters,... |
|
|
P/S
|
Pharmaceutical preparations and substances. |
|
2007
|
P/S
|
Dietetic substances adapted for medical use, food for babies; material for stopping teeth, dental... |
|
|
P/S
|
Food for babies; herbicides. |
